RxDoctor Payments Data

Temitope Afon

Family Medicine · Calhoun, GANPI 1689011181

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $928 and has fallen 89.7% since, to $95 in 2025.

$2,004in general payments, 2019–2025

Across 109 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$220
  • Takeda Pharmaceuticals U.S.A., Inc.$192
  • GSK$190
  • Lilly USA, LLC$178
  • Boehringer Ingelheim$156
  • Amgen$135
  • plus $933 from 24 others

What the payments were for

  • Food & beverage$2,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,004 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia →

Other family medicine in Calhoun

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →